LMNR vs SRPT · rev $42.1M vs rev $1.13B
Limoneira Co (LMNR) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Limoneira Co (LMNR) is a farm products company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported LMNR revenue for 2026-04-30 was $42.1M. Net income was -$30.8M. LMNR currently screens at market cap $230.3M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
LMNR currently screens at market cap $230.3M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the LMNR and SRPT stock pages for the full models.
Not investment advice.